Clinical trial Recruiting at 1 site Interventional Ages 25 to 49 Women only

Patient-centered cervical cancer screening and treatment linkage program in Nairobi

Official title: Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya

Run by Kenyatta National Hospital · NCT07050745 · Data updated 2026-11-12

This project will try a multi-part care approach (DADA LINK) using care coordinators and an mHealth app to help women ages 25–49 in Nairobi get screened for cervical cancer and linked to treatment when needed.

Quick facts

Study typeInterventional
Ages25 Years to 49 Years
SexWomen only
Enrollment1980 (estimated)
SponsorKenyatta National Hospital
Government
Locations1 site (Nairobi)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJanuary 12, 2026
Trial IDNCT07050745 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 25–49 years receiving care at participating Nairobi clinics who are not pregnant, not within six weeks postpartum, and not already confirmed to have cervical cancer.

Probably not a fit

Pregnant women, women ≤6 weeks postpartum, people already confirmed to have cervical cancer, and individuals outside the 25–49 age range are not eligible and would not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Clinics in Nairobi are randomized to implement a multi-component care package (DADA LINK) that uses clinic-based care coordinators and the WEMA mHealth platform to improve HPV self-sampling uptake, screening follow-up, and linkage to treatment for precancerous cervical lesions. Trained study staff will abstract routine clinic records to monitor screening, triage, and treatment rates over a 12-month intervention period with an additional 6-month follow-up to measure costs and maintenance. Care coordinators will support clinic staff to follow cervical cancer care guidelines and will collect patient exit surveys to track intervention fidelity and uptake. The intervention was selected after formative qualitative work and clinic mapping to address barriers at the patient, provider, and facility levels in Nairobi.

Why it matters

Potential benefit: If successful, the program could increase early detection and timely treatment of precancerous cervical lesions, reducing future cervical cancer cases and deaths.

How similar studies have gone: Previous work in low- and middle-income settings has shown promise for HPV self-sampling and mHealth-supported linkage to care, but multi-component, clinic-level coordination packages like DADA LINK are less widely tested in Kenyan primary care.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Women ages 25-49 years

Exclusion Criteria:

* Pregnant women
* Women ≤6 weeks postpartum
* Women already confirmed to have cervical cancer

Where it's running

  • Kenyatta National Hospital
    Nairobi, Kenya
    Recruiting

Study contacts

  • Principal investigator: Rose J Kosgei, MBChB,MMed,MSc,Fell.GynOnc,PhD — University of Nairobi
  • Study coordinator: Agnes K Karume, MBChB, MBA, MPH
  • Email: karumeagnes@gmail.com
  • Phone: +254715181283

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.